Product Description

Kisqali Tablets 200mg contains Ribociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor used in combination with endocrine therapy for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.

Product Overview

Product Name: Kisqali Tablets 200mg

Generic Name: Ribociclib

Strength: 200mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Treatment of HR-positive, HER2-negative advanced or metastatic breast cancer

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Ribociclib 200mg, which inhibits CDK4 and CDK6 proteins, slowing the growth and division of cancer cells.

Key Benefits

• Treats HR-positive, HER2-negative breast cancer
• Slows cancer cell growth
• Used in combination with hormone therapy
• Targeted oral anticancer treatment
• Supports long-term disease management

How to Use

Take exactly as prescribed by your oncologist. Swallow the tablets whole with water, with or without food, following the recommended treatment cycle.

Side Effects & Precautions

Possible Side Effects

• Low white blood cell count
• Fatigue
• Nausea
• Hair thinning
• Liver function changes

Precautions

• Regular blood counts and liver function tests are required.
• ECG monitoring may be recommended during treatment.
• Avoid grapefruit and grapefruit juice.
• Inform your healthcare provider about all medications you are taking.

Storage Instructions

Store below 30°C in a cool, dry place away from moisture and direct sunlight.